Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study

[1]  D. Garver,et al.  State-related changes in cerebral white matter may underlie psychosis exacerbation , 2004, Psychiatry Research: Neuroimaging.

[2]  John Suckling,et al.  The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. , 2004, Brain : a journal of neurology.

[3]  S. Lawrie,et al.  Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia , 2003, Schizophrenia Research.

[4]  D. Garver,et al.  State-related thalamic changes during antipsychotic treatment in schizophrenia: preliminary observations , 2003, Psychiatry Research: Neuroimaging.

[5]  J. Wettstein,et al.  Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping , 2003, Schizophrenia Research.

[6]  B. Cohen,et al.  Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs , 2003, Psychopharmacology.

[7]  Albert Gjedde,et al.  Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo , 2003, Neuropsychopharmacology.

[8]  M. Desco,et al.  Cerebral metabolism and risperidone treatment in schizophrenia , 2003, Schizophrenia Research.

[9]  Andrés Santos,et al.  Cerebral metabolic patterns in chronic and recent-onset schizophrenia , 2003, Psychiatry Research: Neuroimaging.

[10]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[11]  S. Bazire.  Psychotropic Drug Directory: The Professionals' Pocket Handbook and Aide Memoire , 2003 .

[12]  John Suckling,et al.  A computational morphometric MRI study of schizophrenia: effects of hallucinations. , 2002, Cerebral cortex.

[13]  Eve C. Johnstone,et al.  Structural Gray Matter Differences between First-Episode Schizophrenics and Normal Controls Using Voxel-Based Morphometry , 2002, NeuroImage.

[14]  E. Bullmore,et al.  Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation , 2002, Schizophrenia Research.

[15]  Robin M. Murray,et al.  Neurological soft signs in first-episode psychosis: A systematic review , 2002, British Journal of Psychiatry.

[16]  Daniel R Weinberger,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.

[17]  Gabriele Ende,et al.  Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia , 2002, European Neuropsychopharmacology.

[18]  Karl J. Friston,et al.  MRI analysis of an inherited speech and language disorder: structural brain abnormalities. , 2002, Brain : a journal of neurology.

[19]  Fred L. Bookstein,et al.  “Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images , 2001, NeuroImage.

[20]  D. Braus,et al.  Favorable Effect on Neuronal Viability in the Anterior Cingulate Gyrus due to Long-Term Treatment with Atypical Antipsychotics: An MRSI Study , 2001, Pharmacopsychiatry.

[21]  D. Yurgelun-Todd,et al.  Alterations of Thalamic Activity in Schizophrenia and in Response to Antipsychotic Drugs , 2001, Neuropsychopharmacology.

[22]  N. Andreasen,et al.  Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia , 2001, Biological Psychiatry.

[23]  C. Tamminga,et al.  Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia‐thalamocortical neural pathways , 2001, Synapse.

[24]  T. Sigmundsson,et al.  Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. , 2001, The American journal of psychiatry.

[25]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[26]  N C Andreasen,et al.  Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. , 2000, The American journal of psychiatry.

[27]  Dieter F. Braus,et al.  Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia , 2000, Schizophrenia Research.

[28]  Toone.  The bethlem and maudsley NHS trust prescribing guidelines 1999 , 2000, Journal of neurology, neurosurgery, and psychiatry.

[29]  Christer Halldin,et al.  PET Mapping of Extrastriatal D2-like Dopamine Receptors in the Human Brain Using an Anatomic Standardization Technique and [11C]FLB 457 , 1999, NeuroImage.

[30]  R. Murray,et al.  Schizophrenia is (not simply) a neurodevelopmental disorder , 1999, Epidemiology and Psychiatric Sciences.

[31]  R. Kessler,et al.  Cognition, schizophrenia, and the atypical antipsychotic drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Bullmore,et al.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E T Bullmore,et al.  A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images. , 1999, Magnetic resonance imaging.

[34]  N C Andreasen,et al.  Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. , 1999, The American journal of psychiatry.

[35]  S. Tsai,et al.  The effect of acute administration of risperidone on local cerebral glucose utilization in the rat. , 1999, European journal of pharmacology.

[36]  M J Brammer,et al.  Removal of extracerebral tissues in dual-echo magnetic resonance images via linear scale-space features. , 1999, Magnetic resonance imaging.

[37]  K. Abel,et al.  Prescribing guidelines : the bethlem & maudsley NHS trust , 1999 .

[38]  John Suckling,et al.  Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain , 1999, IEEE Transactions on Medical Imaging.

[39]  R. Gur,et al.  Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. , 1998, The American journal of psychiatry.

[40]  C. Heimberg,et al.  Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect , 1998, Psychiatry Research: Neuroimaging.

[41]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[42]  B. Cohen,et al.  Activation of midline thalamic nuclei by antipsychotic drugs , 1998, Psychopharmacology.

[43]  N. Andreasen,et al.  Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography , 1997, Neuropsychopharmacology.

[44]  N. Andreasen,et al.  The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: Assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography , 1997, Biological Psychiatry.

[45]  D R Medoff,et al.  Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.

[46]  Manzar Ashtari,et al.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.

[47]  M. Keshavan,et al.  Changes in caudate volume with neuroleptic treatment , 1994, The Lancet.

[48]  J. Ehrhardt,et al.  Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. , 1994, Science.

[49]  J. Lieberman,et al.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.

[50]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[51]  Joel Jeffries,et al.  Clinical Handbook of Psychotropic Drugs , 1994 .

[52]  Y. Okamoto,et al.  [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol]. , 1993, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.

[53]  Jonathan D. Brodie,et al.  Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia , 1991, Psychiatry Research: Neuroimaging.

[54]  Joseph E. Schwartz,et al.  Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study , 1991, Biological Psychiatry.

[55]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[56]  H. Meltzer,et al.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.

[57]  B. Crosson,et al.  Role of the thalamus in language: is it related to schizophrenic thought disorder? , 1987, Schizophrenia bulletin.

[58]  G. Sedvall,et al.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.

[59]  A Carlsson,et al.  Antipsychotic drugs, neurotransmitters, and schizophrenia. , 1978, The American journal of psychiatry.

[60]  John K. Wing,et al.  Measurement and Classification of Psychiatric Symptoms: An Instruction Manual for the PSE and Catego Program , 1974 .

[61]  M. Annett.  A classification of hand preference by association analysis. , 1970, British journal of psychology.